{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherAbstract": [{"AbstractText": ["Ginkgolide B possesses the antiatherosclerotic advantage of \u201cmultitarget and multipathway\u201d, which is closely linked to its regulating endothelial dysfunction, thrombosis, leukocyte action, and risk factors. [Figure: see text]"]}], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38239238", "DateRevised": {"Year": "2024", "Month": "01", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1016/j.apsb.2023.09.014"], "ArticleDate": [{"Year": "2023", "Month": "09", "Day": "23"}], "Journal": {"ISSN": "2211-3835", "JournalIssue": {"Volume": "14", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Jan"}}, "Title": "Acta pharmaceutica Sinica. B", "ISOAbbreviation": "Acta Pharm Sin B"}, "ArticleTitle": "[Not Available].", "Pagination": {"StartPage": "1", "EndPage": "19", "MedlinePgn": "1-19"}, "Abstract": {"AbstractText": ["Bioactive compounds derived from herbal medicinal plants modulate various therapeutic targets and signaling pathways associated with cardiovascular diseases (CVDs), the world's primary cause of death. <i>Ginkgo biloba</i>, a well-known traditional Chinese medicine with notable cardiovascular actions, has been used as a cardio- and cerebrovascular therapeutic drug and nutraceutical in Asian countries for centuries. Preclinical studies have shown that ginkgolide B, a bioactive component in <i>Ginkgo biloba</i>, can ameliorate atherosclerosis in cultured vascular cells and disease models. Of clinical relevance, several clinical trials are ongoing or being completed to examine the efficacy and safety of ginkgolide B-related drug preparations in the prevention of cerebrovascular diseases, such as ischemia stroke. Here, we present a comprehensive review of the pharmacological activities, pharmacokinetic characteristics, and mechanisms of action of ginkgolide B in atherosclerosis prevention and therapy. We highlight new molecular targets of ginkgolide B, including nicotinamide adenine dinucleotide phosphate oxidases (NADPH oxidase), lectin-like oxidized LDL receptor-1 (LOX-1), sirtuin 1 (SIRT1), platelet-activating factor (PAF), proprotein convertase subtilisin/kexin type 9 (PCSK9) and others. Finally, we provide an overview and discussion of the therapeutic potential of ginkgolide B and highlight the future perspective of developing ginkgolide B as an effective therapeutic agent for treating atherosclerosis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, Guangzhou 510632, China."}, {"Identifier": [], "Affiliation": "Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou 510632, China."}], "LastName": "Ye", "ForeName": "Weile", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, Guangzhou 510632, China."}, {"Identifier": [], "Affiliation": "Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou 510632, China."}], "LastName": "Wang", "ForeName": "Jiaojiao", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacy Australia Centre of Excellence, School of Pharmacy, University of Queensland, Woolloongabba QLD 4102, Australia."}, {"Identifier": [], "Affiliation": "Sunshine Coast Health Institute and School of Health and Behavioural Sciences, University of the Sunshine Coast, Birtinya QLD 4575, Australia."}], "LastName": "Little", "ForeName": "Peter J", "Initials": "PJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, Guangzhou 510632, China."}, {"Identifier": [], "Affiliation": "Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou 510632, China."}], "LastName": "Zou", "ForeName": "Jiami", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, Guangzhou 510632, China."}, {"Identifier": [], "Affiliation": "Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou 510632, China."}], "LastName": "Zheng", "ForeName": "Zhihua", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National-Local Joint Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, Guangzhou 510006, China."}], "LastName": "Lu", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Bengbu Medical College, Bengbu 233030, China."}], "LastName": "Yin", "ForeName": "Yanjun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Bengbu Medical College, Bengbu 233030, China."}], "LastName": "Liu", "ForeName": "Hao", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou 510632, China."}], "LastName": "Zhang", "ForeName": "Dongmei", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National-Local Joint Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, Guangzhou 510006, China."}], "LastName": "Liu", "ForeName": "Peiqing", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Bengbu Medical College, Bengbu 233030, China."}, {"Identifier": [], "Affiliation": "Institute of Endocrine and Metabolic Diseases, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China."}], "LastName": "Xu", "ForeName": "Suowen", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou 510632, China."}], "LastName": "Ye", "ForeName": "Wencai", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, Guangzhou 510632, China."}, {"Identifier": [], "Affiliation": "Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou 510632, China."}], "LastName": "Liu", "ForeName": "Zhiping", "Initials": "Z"}], "PublicationTypeList": ["Journal Article", "Review"], "VernacularTitle": "Anti-atherosclerotic effects and molecular targets of ginkgolide B from <i>Ginkgo biloba</i>."}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Acta Pharm Sin B", "NlmUniqueID": "101600560", "ISSNLinking": "2211-3835"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Weir H.K., Anderson R.N., Coleman King S.M., Soman A., Thompson T.D., Hong Y., et al. Heart disease and cancer deaths\u2014trends and projections in the United States, 1969\u20132020. Prev Chronic Dis. 2016;13:E157.", "ArticleIdList": ["PMC5127176", "27854420"]}, {"Citation": "Tsao C.W., Aday A.W., Almarzooq Z.I., Alonso A., Beaton A.Z., Bittencourt M.S., et al. Heart disease and stroke statistics\u20142022 update: a report from the American Heart Association. Circulation. 2022;145:e153\u2013e639.", "ArticleIdList": ["35078371"]}, {"Citation": "Vos T., Lim S.S., Abbafati C., Abbas K.M., Abbasi M., Abbasifard M., et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204\u20131222.", "ArticleIdList": ["PMC7567026", "33069326"]}, {"Citation": "S\u00e1nchez-Cabo F., Fuster V., Silla-Castro J.C., Gonz\u00e1lez G., Lorenzo-Vivas E., Alvarez R., et al. Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study. Eur Heart J. 2023;44:2698\u20132709.", "ArticleIdList": ["PMC10393076", "37339167"]}, {"Citation": "Zheng B., Yin W.N., Suzuki T., Zhang X.H., Zhang Y., Song L.L., et al. Exosome-mediated miR-155 transfer from smooth muscle cells to endothelial cells induces endothelial injury and promotes atherosclerosis. Mol Ther. 2017;25:1279\u20131294.", "ArticleIdList": ["PMC5475247", "28408180"]}, {"Citation": "Wang J., Uryga A.K., Reinhold J., Figg N., Baker L., Finigan A., et al. Vascular smooth muscle cell senescence promotes atherosclerosis and features of plaque vulnerability. Circulation. 2015;132:1909\u20131919.", "ArticleIdList": ["26416809"]}, {"Citation": "Farina F.M., Serio S., Hall I.F., Zani S., Cassanmagnago G.A., Climent M., et al. The epigenetic enzyme DOT1L orchestrates vascular smooth muscle cell-monocyte crosstalk and protects against atherosclerosis via the NF-\u03baB pathway. Eur Heart J. 2022;43:4562\u20134576.", "ArticleIdList": ["35292818"]}, {"Citation": "Orecchioni M., Kobiyama K., Winkels H., Ghosheh Y., McArdle S., Mikulski Z., et al. Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production. Science. 2022;375:214\u2013221.", "ArticleIdList": ["PMC9744443", "35025664"]}, {"Citation": "Amadori L., Calcagno C., Fernandez D.M., Koplev S., Fernandez N., Kaur R., et al. Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis. Nat Cardiovasc Res. 2023;2:550\u2013571.", "ArticleIdList": ["PMC10538622", "37771373"]}, {"Citation": "Mauersberger C., Sager H.B., Wobst J., Dang T.A., Lambrecht L., Koplev S., et al. Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation. Nat Cardiovasc Res. 2022;1:1174\u20131186.", "ArticleIdList": ["PMC10361702", "37484062"]}, {"Citation": "Momi S., Falcinelli E., Petito E., Ciarrocca Taranta G., Ossoli A., Gresele P. Matrix metalloproteinase-2 on activated platelets triggers endothelial PAR-1 initiating atherosclerosis. Eur Heart J. 2022;43:504\u2013514.", "ArticleIdList": ["34529782"]}, {"Citation": "Schumski A., Ortega-G\u00f3mez A., Wichapong K., Winter C., Lemnitzer P., Viola J.R., et al. Endotoxinemia accelerates atherosclerosis through electrostatic charge-mediated monocyte adhesion. Circulation. 2021;143:254\u2013266.", "ArticleIdList": ["PMC7914394", "33167684"]}, {"Citation": "Mohanta S.K., Peng L., Li Y., Lu S., Sun T., Carnevale L., et al. Neuroimmune cardiovascular interfaces control atherosclerosis. Nature. 2022;605:152\u2013159.", "ArticleIdList": ["35477759"]}, {"Citation": "Xu S., Ilyas I., Little P.J., Li H., Kamato D., Zheng X., et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev. 2021;73:924\u2013967.", "ArticleIdList": ["34088867"]}, {"Citation": "Little P.J., Osman N., O'Brien K.D. Hyperelongated biglycan: the surreptitious initiator of atherosclerosis. Curr Opin Lipidol. 2008;19:448\u2013454.", "ArticleIdList": ["18769225"]}, {"Citation": "Tsiantoulas D., Eslami M., Obermayer G., Clement M., Smeets D., Mayer F.J., et al. APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans. Nature. 2021;597:92\u201396.", "ArticleIdList": ["34433968"]}, {"Citation": "Sakata N., Uesugi N., Takebayashi S., Nagai R., Jono T., Horiuchi S., et al. Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis. Cardiovasc Res. 2001;49:466\u2013475.", "ArticleIdList": ["11164857"]}, {"Citation": "Li C., Qu L., Matz A.J., Murphy P.A., Liu Y., Manichaikul A.W., et al. AtheroSpectrum reveals novel macrophage foam cell gene signatures associated with atherosclerotic cardiovascular disease risk. Circulation. 2022;145:206\u2013218.", "ArticleIdList": ["PMC8766929", "34913723"]}, {"Citation": "Luo Y., Duan H., Qian Y., Feng L., Wu Z., Wang F., et al. Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis. Cell Res. 2017;27:352\u2013372.", "ArticleIdList": ["PMC5339843", "28084332"]}, {"Citation": "Hong M.K., Mintz G.S., Lee C.W., Kim Y.H., Lee S.W., Song J.M., et al. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation. 2004;110:928\u2013933.", "ArticleIdList": ["15313951"]}, {"Citation": "Bergstr\u00f6m G., Persson M., Adiels M., Bj\u00f6rnson E., Bonander C., Ahlstr\u00f6m H., et al. Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation. 2021;144:916\u2013929.", "ArticleIdList": ["PMC8448414", "34543072"]}, {"Citation": "Uzhova I., Fuster V., Fern\u00e1ndez-Ortiz A., Ordov\u00e1s J.M., Sanz J., Fern\u00e1ndez-Friera L., et al. The importance of breakfast in atherosclerosis disease: insights from the PESA study. J Am Coll Cardiol. 2017;70:1833\u20131842.", "ArticleIdList": ["28982495"]}, {"Citation": "Lyu M., Cui Y., Zhao T., Ning Z., Ren J., Jin X., et al. Mediated atherosclerosis signaling and inflammatory response as a common protection mechanism of shuxuening injection against both myocardial and cerebral ischemia\u2013reperfusion injuries. Front Pharmacol. 2018;9:312.", "ArticleIdList": ["PMC5897438", "29681850"]}, {"Citation": "Wu Y., Li S., Cui W., Zu X., Du J., Wang F. Ginkgo biloba extract improves coronary blood flow in healthy elderly adults: role of endothelium-dependent vasodilation. Phytomedicine. 2008;15:164\u2013169.", "ArticleIdList": ["18258419"]}, {"Citation": "Wu Y.Z., Li S.Q., Zu X.G., Du J., Wang F.F. Ginkgo biloba extract improves coronary artery circulation in patients with coronary artery disease: contribution of plasma nitric oxide and endothelin-1. Phytother Res. 2008;22:734\u2013739.", "ArticleIdList": ["18446847"]}, {"Citation": "Xiao G., Lyu M., Wang Y., He S., Liu X., Ni J., et al. Ginkgo flavonol glycosides or ginkgolides tend to differentially protect myocardial or cerebral ischemia\u2013reperfusion injury regulation of TWEAK\u2013Fn14 signaling in heart and brain. Front Pharmacol. 2019;10:735.", "ArticleIdList": ["PMC6624656", "31333457"]}, {"Citation": "Ngan N.T., Quang T.H., Tai B.H., Song S.B., Lee D., Kim Y.H. Anti-inflammatory and PPAR transactivational effects of components from the stem bark of Ginkgo biloba. J Agric Food Chem. 2012;60:2815\u20132824.", "ArticleIdList": ["22352956"]}, {"Citation": "Li M., Xia Z.M., Li B., Tian Y., Zhang G-j, Xu C., et al. Chemical constituents from Ginkgo biloba L. male flowers and their biological activities. Med Chem Res. 2019;28:1557\u20131566."}, {"Citation": "Bolshakov S., Dzyuba S.V., Decatur J., Nakanishi K. A concise synthesis of ginkgolide M, a minor component of a terpene trilactone fraction from Ginkgo biloba roots. J Nat Prod. 2006;69:429\u2013431.", "ArticleIdList": ["16562852"]}, {"Citation": "Liao H.J., Zheng Y.F., Li H.Y., Peng G.P. Two new ginkgolides from the leaves of Ginkgo biloba. Planta Med. 2011;77:1818\u20131821.", "ArticleIdList": ["21614751"]}, {"Citation": "Weinges K., Hepp M., Jaggy H. Chemie der ginkgolide, II. Isolierung und strukturaufkl\u00e4rung eines neuen ginkgolids. Liebigs Ann Chem. 1987;1987:521\u2013526."}, {"Citation": "Ma S., Liu X., Xu Q., Zhang X. Transport of ginkgolides with different lipophilicities based on an hCMEC/D3 cell monolayer as a blood\u2013brain barrier cell model. Life Sci. 2014;114:93\u2013101.", "ArticleIdList": ["25139831"]}, {"Citation": "Liu X., Zhao G., Yan Y., Bao L., Chen B., Qi R. Ginkgolide B reduces atherogenesis and vascular inflammation in ApoE\u2013/\u2013 mice. PLoS One. 2012;7", "ArticleIdList": ["PMC3359353", "22662117"]}, {"Citation": "Lv Z., Shan X., Tu Q., Wang J., Chen J., Yang Y. Ginkgolide B treatment regulated intestinal flora to improve high-fat diet induced atherosclerosis in ApoE mice. Biomed Pharmacother. 2021;134", "ArticleIdList": ["33341056"]}, {"Citation": "Feng Z., Yang X., Zhang L., Ansari I.A., Khan M.S., Han S., et al. Ginkgolide B ameliorates oxidized low-density lipoprotein-induced endothelial dysfunction via modulating lectin-like ox-LDL-receptor-1 and NADPH oxidase 4 expression and inflammatory cascades. Phytother Res. 2018;32:2417\u20132427.", "ArticleIdList": ["30136446"]}, {"Citation": "Li R., Chen B., Wu W., Bao L., Li J., Qi R. Ginkgolide B suppresses intercellular adhesion molecule-1 expression via blocking nuclear factor-kappaB activation in human vascular endothelial cells stimulated by oxidized low-density lipoprotein. J Pharmacol Sci. 2009;110:362\u2013369.", "ArticleIdList": ["19609067"]}, {"Citation": "Liu X., Sun W., Zhao Y., Chen B., Wu W., Bao L., et al. Ginkgolide B inhibits JAM-A, Cx43, and VE-Cadherin expression and reduces monocyte transmigration in oxidized LDL-stimulated human umbilical vein endothelial cells. Oxid Med Cell Longev. 2015;2015", "ArticleIdList": ["PMC4515296", "26246869"]}, {"Citation": "Ma L., Liu X., Zhao Y., Chen B., Li X., Qi R. Ginkgolide B reduces LOX-1 expression by inhibiting Akt phosphorylation and increasing Sirt1 expression in oxidized LDL-stimulated human umbilical vein endothelial cells. PLoS One. 2013;8", "ArticleIdList": ["PMC3775799", "24069345"]}, {"Citation": "Zhang M., Sun J., Chen B., Zhao Y., Gong H., You Y., et al. Ginkgolide B inhibits platelet and monocyte adhesion in TNF\u03b1-treated HUVECs under laminar shear stress. BMC Compl Alternative Med. 2018;18:220.", "ArticleIdList": ["PMC6053749", "30029641"]}, {"Citation": "Liu X., Yan Y., Bao L., Chen B., Zhao Y., Qi R. Ginkgolide B inhibits platelet release by blocking Syk and p38 MAPK phosphorylation in thrombin-stimulated platelets. Thromb Res. 2014;134:1066\u20131073.", "ArticleIdList": ["25223809"]}, {"Citation": "Wang G., Liu Z.B., Li M.H., Li Y., Alvi S.S., Ansari I.A., et al. Ginkgolide B mediated alleviation of inflammatory cascades and altered lipid metabolism in HUVECs via targeting PCSK-9 expression and functionality. BioMed Res Int. 2019;2019", "ArticleIdList": ["PMC6590504", "31281844"]}, {"Citation": "Zhang S., Chen B., Wu W., Bao L., Qi R. Ginkgolide B reduces inflammatory protein expression in oxidized low-density lipoprotein-stimulated human vascular endothelial cells. J Cardiovasc Pharmacol. 2011;57:721\u2013727.", "ArticleIdList": ["21436722"]}, {"Citation": "Zhang R., Xu L., Zhang D., Hu B., Luo Q., Han D., et al. Cardioprotection of ginkgolide B on myocardial ischemia/reperfusion-induced inflammatory injury via regulation of A20-NF-\u03baB pathway. Front Immunol. 2018;9:2844.", "ArticleIdList": ["PMC6299132", "30619251"]}, {"Citation": "Zheng S., Li Z., Song J., Wang P., Xu J., Hu W., et al. Endothelial METRNL determines circulating METRNL level and maintains endothelial function against atherosclerosis. Acta Pharm Sin B. 2023;13:1568\u20131587.", "ArticleIdList": ["PMC10149902", "37139425"]}, {"Citation": "Theilmeier G., Michiels C., Spaepen E., Vreys I., Collen D., Vermylen J., et al. Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood. 2002;99:4486\u20134493.", "ArticleIdList": ["12036879"]}, {"Citation": "Popa M., Tahir S., Elrod J., Kim S.H., Leuschner F., Kessler T., et al. Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell\u2013platelet\u2013monocyte interaction. Proc Natl Acad Sci U\u00a0S\u00a0A. 2018;115:E5556\u2013E5565.", "ArticleIdList": ["PMC6004483", "29793936"]}, {"Citation": "Frodermann V., Rohde D., Courties G., Severe N., Schloss M.J., Amatullah H., et al. Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells. Nat Med. 2019;25:1761\u20131771.", "ArticleIdList": ["PMC6858591", "31700184"]}, {"Citation": "Chen P.Y., Qin L., Li G., Wang Z., Dahlman J.E., Malagon-Lopez J., et al. Endothelial TGF-\u03b2 signalling drives vascular inflammation and atherosclerosis. Nat Metab. 2019;1:912\u2013926.", "ArticleIdList": ["PMC6767930", "31572976"]}, {"Citation": "Xu S., Xu Y., Liu P., Zhang S., Liu H., Slavin S., et al. The novel coronary artery disease risk gene JCAD/KIAA1462 promotes endothelial dysfunction and atherosclerosis. Eur Heart J. 2019;40:2398\u20132408.", "ArticleIdList": ["PMC6698662", "31539914"]}, {"Citation": "Anisimov A., Fang S., Hemanthakumar K.A., \u00d6rd T., van Avondt K., Chevre R., et al. The angiopoietin receptor Tie2 is atheroprotective in arterial endothelium. Nat Cardiovasc Res. 2023;2:307\u2013321.", "ArticleIdList": ["PMC7614785", "37476204"]}, {"Citation": "Jia M., Li Q., Guo J., Shi W., Zhu L., Huang Y., et al. Deletion of BACH1 attenuates atherosclerosis by reducing endothelial inflammation. Circ Res. 2022;130:1038\u20131055.", "ArticleIdList": ["35196865"]}, {"Citation": "Liu Z., Zhu H., Dai X., Wang C., Ding Y., Song P., et al. Macrophage liver kinase B1 inhibits foam cell formation and atherosclerosis. Circ Res. 2017;121:1047\u20131057.", "ArticleIdList": ["PMC5640502", "28827412"]}, {"Citation": "Ozawa K., Muller M.A., Varlamov O., Tavori H., Packwood W., Mueller P.A., et al. Proteolysis of Von Willebrand factor influences inflammatory endothelial activation and vascular compliance in atherosclerosis. JACC Basic Transl Sci. 2020;5:1017\u20131028.", "ArticleIdList": ["PMC7591934", "33145464"]}, {"Citation": "El-Mansi S., Robinson C.L., Kostelnik K.B., McCormack J.J., Mitchell T.P., Lobato-M\u00e1rquez D., et al. Proximity proteomics identifies septins and PAK2 as decisive regulators of actomyosin-mediated expulsion of von Willebrand factor. Blood. 2023;141:930\u2013944.", "ArticleIdList": ["PMC10023740", "36564030"]}, {"Citation": "Qi Z., Hu L., Zhang J., Yang W., Liu X., Jia D., et al. PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) enhances platelet activation, thrombosis, and myocardial infarct expansion by binding to platelet CD36. Circulation. 2021;143:45\u201361.", "ArticleIdList": ["32988222"]}, {"Citation": "Warnatsch A., Ioannou M., Wang Q., Papayannopoulos V. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science. 2015;349:316\u2013320.", "ArticleIdList": ["PMC4854322", "26185250"]}, {"Citation": "Willems S., Vink A., Bot I., Quax P.H., de Borst G.J., de Vries J.P., et al. Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events. Eur Heart J. 2013;34:3699\u20133706.", "ArticleIdList": ["23756333"]}, {"Citation": "Landmesser U., Hornig B., Drexler H. Endothelial function: a critical determinant in atherosclerosis?. Circulation. 2004;109:II27\u2013II33.", "ArticleIdList": ["15173060"]}, {"Citation": "Dong Y., Wang B., Du M., Zhu B., Cui K., Li K., et al. Targeting epsins to inhibit fibroblast growth factor signaling while potentiating transforming growth factor-beta signaling constrains endothelial-to-mesenchymal transition in atherosclerosis. Circulation. 2023;147:669\u2013685.", "ArticleIdList": ["PMC10136057", "36591786"]}, {"Citation": "Sch\u00fcrmann C., Rezende F., Kruse C., Yasar Y., L\u00f6we O., Fork C., et al. The NADPH oxidase Nox4 has anti-atherosclerotic functions. Eur Heart J. 2015;36:3447\u20133456.", "ArticleIdList": ["PMC4751217", "26385958"]}, {"Citation": "Drummond G.R., Selemidis S., Griendling K.K., Sobey C.G. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov. 2011;10:453\u2013471.", "ArticleIdList": ["PMC3361719", "21629295"]}, {"Citation": "Jiang J., Huang K., Xu S., Garcia J.G.N., Wang C., Cai H. Targeting NOX4 alleviates sepsis-induced acute lung injury via attenuation of redox-sensitive activation of CaMKII/ERK1/2/MLCK and endothelial cell barrier dysfunction. Redox Biol. 2020;36", "ArticleIdList": ["PMC7381685", "32863203"]}, {"Citation": "Helmcke I., Heum\u00fcller S., Tikkanen R., Schr\u00f6der K., Brandes R.P. Identification of structural elements in Nox1 and Nox4 controlling localization and activity. Antioxidants Redox Signal. 2009;11:1279\u20131287.", "ArticleIdList": ["19061439"]}, {"Citation": "Takac I., Schr\u00f6der K., Zhang L., Lardy B., Anilkumar N., Lambeth J.D., et al. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J Biol Chem. 2011;286:13304\u201313313.", "ArticleIdList": ["PMC3075677", "21343298"]}, {"Citation": "Xu H., Goettsch C., Xia N., Horke S., Morawietz H., F\u00f6rstermann U., et al. Differential roles of PKCalpha and PKCepsilon in controlling the gene expression of Nox4 in human endothelial cells. Free Radic Biol Med. 2008;44:1656\u20131667.", "ArticleIdList": ["18291120"]}, {"Citation": "Yu W., Li S., Wu H., Hu P., Chen L., Zeng C., et al. Endothelial Nox4 dysfunction aggravates atherosclerosis by inducing endoplasmic reticulum stress and soluble epoxide hydrolase. Free Radic Biol Med. 2021;164:44\u201357.", "ArticleIdList": ["33418110"]}, {"Citation": "Sorescu D., Weiss D., Lass\u00e8gue B., Clempus R.E., Sz\u00f6cs K., Sorescu G.P., et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation. 2002;105:1429\u20131435.", "ArticleIdList": ["11914250"]}, {"Citation": "Xu S., Chamseddine A.H., Carrell S., Miller F.J. Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques. Redox Biol. 2014;2:642\u2013650.", "ArticleIdList": ["PMC4052526", "24936437"]}, {"Citation": "Wang G.G., Chen Q.Y., Li W., Lu X.H., Zhao X. Ginkgolide B increases hydrogen sulfide and protects against endothelial dysfunction in diabetic rats. Croat Med J. 2015;56:4\u201313.", "ArticleIdList": ["PMC4364347", "25727037"]}, {"Citation": "Ma W., Li J., Hu J., Cheng Y., Wang J., Zhang X., et al. miR214-regulated p53-NOX4/p66shc pathway plays a crucial role in the protective effect of ginkgolide B against cisplatin-induced cytotoxicity in HEI-OC1 cells. Chem Biol Interact. 2016;245:72\u201381.", "ArticleIdList": ["26768586"]}, {"Citation": "Kim Y.M., Kim S.J., Tatsunami R., Yamamura H., Fukai T., Ushio-Fukai M. ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis. Am J Physiol Cell Physiol. 2017;312:C749\u2013C764.", "ArticleIdList": ["PMC5494593", "28424170"]}, {"Citation": "Yang Z., Yang Y., Xiong K., Li X., Qi P., Tu Q., et al. Nitric oxide producing coating mimicking endothelium function for multifunctional vascular stents. Biomaterials. 2015;63:80\u201392.", "ArticleIdList": ["26093790"]}, {"Citation": "Casas J.P., Bautista L.E., Humphries S.E., Hingorani A.D. Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation. 2004;109:1359\u20131365.", "ArticleIdList": ["15007011"]}, {"Citation": "Ozaki M., Kawashima S., Yamashita T., Hirase T., Namiki M., Inoue N., et al. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J Clin Invest. 2002;110:331\u2013340.", "ArticleIdList": ["PMC151086", "12163452"]}, {"Citation": "Kim T.K., Jeon S., Park S., Sonn S.K., Seo S., Suh J., et al. 2\u2032\u20135\u2032 Oligoadenylate synthetase-like 1 (OASL1) protects against atherosclerosis by maintaining endothelial nitric oxide synthase mRNA stability. Nat Commun. 2022;13:6647.", "ArticleIdList": ["PMC9636244", "36333342"]}, {"Citation": "Mount P.F., Kemp B.E., Power D.A. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol. 2007;42:271\u2013279.", "ArticleIdList": ["16839566"]}, {"Citation": "Jin Y.J., Chennupati R., Li R., Liang G.Z., Wang S.P., Iring A., et al. Protein kinase N2 mediates flow-induced endothelial NOS activation and vascular tone regulation. J Clin Invest. 2021;131", "ArticleIdList": ["PMC8553558", "34499618"]}, {"Citation": "Hambrecht R., Adams V., Erbs S., Linke A., Kr\u00e4nkel N., Shu Y., et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation. 2003;107:3152\u20133158.", "ArticleIdList": ["12810615"]}, {"Citation": "Jing C., Zhang G., Liu Z., Xu Q., Li C., Cheng G., et al. Peroxidasin promotes diabetic vascular endothelial dysfunction induced by advanced glycation end products via NOX2/HOCl/Akt/eNOS pathway. Redox Biol. 2021;45", "ArticleIdList": ["PMC8192873", "34116361"]}, {"Citation": "Predmore B.L., Julian D., Cardounel A.J. Hydrogen sulfide increases nitric oxide production from endothelial cells by an Akt-dependent mechanism. Front Physiol. 2011;2:104.", "ArticleIdList": ["PMC3242361", "22194727"]}, {"Citation": "Tang Y., Huang B., Sun L., Peng X., Chen X., Zou X. Ginkgolide B promotes proliferation and functional activities of bone marrow-derived endothelial progenitor cells: involvement of Akt/eNOS and MAPK/p38 signaling pathways. Eur Cell Mater. 2011;21:459\u2013469.", "ArticleIdList": ["21623570"]}, {"Citation": "Akhmedov A., Rozenberg I., Paneni F., Camici G.G., Shi Y., Doerries C., et al. Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in\u00a0vivo. Eur Heart J. 2014;35:2839\u20132848.", "ArticleIdList": ["24419805"]}, {"Citation": "Mehta J.L., Basnakian A.G. Interaction of carbamylated LDL with LOX-1 in the induction of endothelial dysfunction and atherosclerosis. Eur Heart J. 2014;35:2996\u20132997.", "ArticleIdList": ["24694664"]}, {"Citation": "Chen J., Mehta J.L., Haider N., Zhang X., Narula J., Li D. Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res. 2004;94:370\u2013376.", "ArticleIdList": ["14684629"]}, {"Citation": "Zhu T.T., Zhang W.F., Luo P., Qian Z.X., Li F., Zhang Z., et al. LOX-1 promotes right ventricular hypertrophy in hypoxia-exposed rats. Life Sci. 2017;174:35\u201342.", "ArticleIdList": ["28259654"]}, {"Citation": "Bai B., Liang Y., Xu C., Lee M.Y., Xu A., Wu D., et al. Cyclin-dependent kinase 5-mediated hyperphosphorylation of sirtuin-1 contributes to the development of endothelial senescence and atherosclerosis. Circulation. 2012;126:729\u2013740.", "ArticleIdList": ["22753194"]}, {"Citation": "Gerdes N., Seijkens T., Lievens D., Kuijpers M.J., Winkels H., Projahn D., et al. Platelet CD40 exacerbates atherosclerosis by transcellular activation of endothelial cells and leukocytes. Arterioscler Thromb Vasc Biol. 2016;36:482\u2013490.", "ArticleIdList": ["26821950"]}, {"Citation": "Huo Y., Schober A., Forlow S.B., Smith D.F., Hyman M.C., Jung S., et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med. 2003;9:61\u201367.", "ArticleIdList": ["12483207"]}, {"Citation": "Barrett T.J., Schlegel M., Zhou F., Gorenchtein M., Bolstorff J., Moore K.J., et al. Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis. Sci Transl Med. 2019;11", "ArticleIdList": ["PMC6905432", "31694925"]}, {"Citation": "Yeung J., Li W., Holinstat M. Platelet signaling and disease: targeted therapy for thrombosis and other related diseases. Pharmacol Rev. 2018;70:526\u2013548.", "ArticleIdList": ["PMC6013590", "29925522"]}, {"Citation": "King S.M., McNamee R.A., Houng A.K., Patel R., Brands M., Reed G.L. Platelet dense-granule secretion plays a critical role in thrombosis and subsequent vascular remodeling in atherosclerotic mice. Circulation. 2009;120:785\u2013791.", "ArticleIdList": ["PMC2761818", "19687360"]}, {"Citation": "DeFilippis A.P., Trainor P.J., Thanassoulis G., Brumback L.C., Post W.S., Tsai M.Y., et al. Atherothrombotic factors and atherosclerotic cardiovascular events: the multi-ethnic study of atherosclerosis. Eur Heart J. 2022;43:971\u2013981.", "ArticleIdList": ["PMC8899529", "34508626"]}, {"Citation": "Saha P., Gutmann C., Kingdon J., Dregan A., Bertolaccini L., Grover S.P., et al. Venous thrombosis accelerates atherosclerosis in mice. Circulation. 2023;147:1945\u20131947.", "ArticleIdList": ["37335825"]}, {"Citation": "Frenette P.S., Johnson R.C., Hynes R.O., Wagner D.D. Platelets roll on stimulated endothelium in\u00a0vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci U\u00a0S\u00a0A. 1995;92:7450\u20137454.", "ArticleIdList": ["PMC41357", "7543682"]}, {"Citation": "Frenette P.S., Moyna C., Hartwell D.W., Lowe J.B., Hynes R.O., Wagner D.D. Platelet-endothelial interactions in inflamed mesenteric venules. Blood. 1998;91:1318\u20131324.", "ArticleIdList": ["9454762"]}, {"Citation": "Frenette P.S., Denis C.V., Weiss L., Jurk K., Subbarao S., Kehrel B., et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet\u2013endothelial interactions in\u00a0vivo. J Exp Med. 2000;191:1413\u20131422.", "ArticleIdList": ["PMC2193129", "10770806"]}, {"Citation": "Romo G.M., Dong J.F., Schade A.J., Gardiner E.E., Kansas G.S., Li C.Q., et al. The glycoprotein Ib\u2013IX\u2013V complex is a platelet counterreceptor for P-selectin. J Exp Med. 1999;190:803\u2013814.", "ArticleIdList": ["PMC2195629", "10499919"]}, {"Citation": "Jalkanen S., Karikoski M., Mercier N., Koskinen K., Henttinen T., Elima K., et al. The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding. Blood. 2007;110:1864\u20131870.", "ArticleIdList": ["17548577"]}, {"Citation": "Merten M., Chow T., Hellums J.D., Thiagarajan P. A new role for P-selectin in shear-induced platelet aggregation. Circulation. 2000;102:2045\u20132050.", "ArticleIdList": ["11044418"]}, {"Citation": "Massberg S., Enders G., Leiderer R., Eisenmenger S., Vestweber D., Krombach F., et al. Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood. 1998;92:507\u2013515.", "ArticleIdList": ["9657750"]}, {"Citation": "Yokoyama S., Ikeda H., Haramaki N., Yasukawa H., Murohara T., Imaizumi T. Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet\u2013leukocyte aggregates. J Am Coll Cardiol. 2005;45:1280\u20131286.", "ArticleIdList": ["15837262"]}, {"Citation": "Dole V.S., Bergmeier W., Mitchell H.A., Eichenberger S.C., Wagner D.D. Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in\u00a0vivo: role of P-selectin. Blood. 2005;106:2334\u20132339.", "ArticleIdList": ["PMC1895274", "15956287"]}, {"Citation": "Phillips J.W., Barringhaus K.G., Sanders J.M., Hesselbacher S.E., Czarnik A.C., Manka D., et al. Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation. 2003;107:2244\u20132249.", "ArticleIdList": ["12707243"]}, {"Citation": "Garland R.C., Sun D., Zandi S., Xie F., Faez S., Tayyari F., et al. Noninvasive molecular imaging reveals role of PAF in leukocyte-endothelial interaction in LPS-induced ocular vascular injury. Faseb J. 2011;25:1284\u20131294.", "ArticleIdList": ["PMC3058708", "21257713"]}, {"Citation": "Coller B.S. \u03b1IIb\u03b23: structure and function. J Thromb Haemostasis. 2015;13(Suppl 1):S17\u2013S25.", "ArticleIdList": ["PMC4888797", "26149019"]}, {"Citation": "Gawaz M., Neumann F.J., Dickfeld T., Reininger A., Adelsberger H., Gebhardt A., et al. Vitronectin receptor (\u03b1v\u03b23) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation. 1997;96:1809\u20131818.", "ArticleIdList": ["9323066"]}, {"Citation": "Reininger A.J., Agneskirchner J., Bode P.A., Spannagl M., Wurzinger L.J. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor\u2014results from patients with acute myocardial infarction and healthy controls. Thromb Haemostasis. 2000;83:217\u2013223.", "ArticleIdList": ["10739376"]}, {"Citation": "Huang J., Li X., Shi X., Zhu M., Wang J., Huang S., et al. Platelet integrin \u03b1IIb\u03b23: signal transduction, regulation, and its therapeutic targeting. J Hematol Oncol. 2019;12:26.", "ArticleIdList": ["PMC6407232", "30845955"]}, {"Citation": "Shang Q., Zhou X., Yang M.R., Lu J.G., Pan Y., Zhu G.Y., et al. Amide derivatives of ginkgolide B and their inhibitory effects on paf-induced platelet aggregation. ACS Omega. 2021;6:22497\u201322503.", "ArticleIdList": ["PMC8427636", "34514222"]}, {"Citation": "Li X.S., Zheng W.Y., Lou S.X., Lu X.W., Ye S.H. Effect of Ginkgo leaf extract on vascular endothelial function in patients with early stage diabetic nephropathy. Chin J Integr Med. 2009;15:26\u201329.", "ArticleIdList": ["19271166"]}, {"Citation": "Zhang H., Cao Y., Pei H., Wang H., Ma L., Wang Z., et al. Shenmayizhi formula combined with ginkgo extract tablets for the treatment of vascular dementia: a randomized, double-blind, controlled trial. Evid Based Complement Alternat Med. 2020;2020", "ArticleIdList": ["PMC7397431", "32774430"]}, {"Citation": "Lee C.M., Jung W.K., Na G., Lee D.S., Park S.G., Seo S.K., et al. Inhibitory effects of the platelet-activating factor receptor antagonists, CV-3988 and Ginkgolide B, on alkali burn-induced corneal neovascularization. Cutan Ocul Toxicol. 2015;34:53\u201360.", "ArticleIdList": ["24754407"]}, {"Citation": "Xia S.H., Hu C.X., Zhao Z.L., Xia G.D., Di Y. Significance of platelet activating factor receptor expression in pancreatic tissues of rats with severe acute pancreatitis and effects of BN52021. World J Gastroenterol. 2007;13:2992\u20132998.", "ArticleIdList": ["PMC4171155", "17589953"]}, {"Citation": "Kondratskaya E.L., Pankratov Y.V., Lalo U.V., Chatterjee S.S., Krishtal O.A. Inhibition of hippocampal LTP by ginkgolide B is mediated by its blocking action on PAF rather than glycine receptors. Neurochem Int. 2004;44:171\u2013177.", "ArticleIdList": ["14568560"]}, {"Citation": "Hyland I.K., O'Toole R.F., Smith J.A., Bissember A.C. Progress in the development of platelet-activating factor receptor (PAFr) antagonists and applications in the treatment of inflammatory diseases. ChemMedChem. 2018;13:1873\u20131884.", "ArticleIdList": ["30009544"]}, {"Citation": "Tjoelker L.W., Wilder C., Eberhardt C., Stafforini D.M., Dietsch G., Schimpf B., et al. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature. 1995;374:549\u2013553.", "ArticleIdList": ["7700381"]}, {"Citation": "Heery J.M., Kozak M., Stafforini D.M., Jones D.A., Zimmerman G.A., McIntyre T.M., et al. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest. 1995;96:2322\u20132330.", "ArticleIdList": ["PMC185883", "7593619"]}, {"Citation": "Nakamura M., Honda Z., Waga I., Matsumoto T., Noma M., Shimizu T. Endotoxin transduces Ca2+ signaling via platelet-activating factor receptor. FEBS Lett. 1992;314:125\u2013129.", "ArticleIdList": ["1333988"]}, {"Citation": "Ji R.L., Xia S.H., Di Y., Xu W. Mechanism and dose-effect of gginkgolide B on severe acute pancreatitis of rats. World J Gastroenterol. 2011;17:2241\u20132247.", "ArticleIdList": ["PMC3092878", "21633536"]}, {"Citation": "Xia S.H., Xiang X.H., Chen K., Xu W. Roles of BN52021 in platelet-activating factor pathway in inflammatory MS1 cells. World J Gastroenterol. 2013;19:3969\u20133979.", "ArticleIdList": ["PMC3703183", "23840141"]}, {"Citation": "Montrucchio G., Bergerone S., Bussolino F., Alloatti G., Silvestro L., Lupia E., et al. Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells. Circulation. 1993;88:1476\u20131483.", "ArticleIdList": ["8403295"]}, {"Citation": "Chakrabarty S., Thomas P., Sheridan D.J. Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischaemia. Eur Heart J. 1991;12:583\u2013589.", "ArticleIdList": ["1874258"]}, {"Citation": "Wainwright C.L., Parratt J.R., Bigaud M. The effects of PAF antagonists on arrhythmias and platelets during acute myocardial ischaemia and reperfusion. Eur Heart J. 1989;10:235\u2013243.", "ArticleIdList": ["2468494"]}, {"Citation": "Estevez B., Du X. New concepts and mechanisms of platelet activation signaling. Physiology. 2017;32:162\u2013177.", "ArticleIdList": ["PMC5337829", "28228483"]}, {"Citation": "Golino P., Ambrosio G., Ragni M., Pascucci I., Triggiani M., Oriente A., et al. Short-term and long-term role of platelet activating factor as a mediator of in\u00a0vivo platelet aggregation. Circulation. 1993;88:1205\u20131214.", "ArticleIdList": ["8353882"]}, {"Citation": "Eslin D.E., Zhang C., Samuels K.J., Rauova L., Zhai L., Niewiarowski S., et al. Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. Blood. 2004;104:3173\u20133180.", "ArticleIdList": ["14764524"]}, {"Citation": "Nassar T., Sachais B.S., Akkawi S., Kowalska M.A., Bdeir K., Leitersdorf E., et al. Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells. J Biol Chem. 2003;278:6187\u20136193.", "ArticleIdList": ["12466273"]}, {"Citation": "Scheuerer B., Ernst M., D\u00fcrrbaum-Landmann I., Fleischer J., Grage-Griebenow E., Brandt E., et al. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood. 2000;95:1158\u20131166.", "ArticleIdList": ["10666185"]}, {"Citation": "Lievens D., Zernecke A., Seijkens T., Soehnlein O., Beckers L., Munnix I.C., et al. Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood. 2010;116:4317\u20134327.", "ArticleIdList": ["PMC2993630", "20705757"]}, {"Citation": "Weber C., Zernecke A., Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol. 2008;8:802\u2013815.", "ArticleIdList": ["18825131"]}, {"Citation": "Liu W., Yalcinkaya M., Maestre I.F., Olszewska M., Ampomah P.B., Heimlich J.B., et al. Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis. Nat Cardiovasc Res. 2023;2:572\u2013586.", "ArticleIdList": ["PMC10399458", "37539077"]}, {"Citation": "Hinterdobler J., Schott S., Jin H., Meesmann A., Steinsiek A.L., Zimmermann A.S., et al. Acute mental stress drives vascular inflammation and promotes plaque destabilization in mouse atherosclerosis. Eur Heart J. 2021;42:4077\u20134088.", "ArticleIdList": ["PMC8516477", "34279021"]}, {"Citation": "Sans M., Pan\u00e9s J., Ardite E., Elizalde J.I., Arce Y., Elena M., et al. VCAM-1 and ICAM-1 mediate leukocyte\u2013endothelial cell adhesion in rat experimental colitis. Gastroenterology. 1999;116:874\u2013883.", "ArticleIdList": ["10092309"]}, {"Citation": "Vestweber D. How leukocytes cross the vascular endothelium. Nat Rev Immunol. 2015;15:692\u2013704.", "ArticleIdList": ["26471775"]}, {"Citation": "Collins R.G., Velji R., Guevara N.V., Hicks M.J., Chan L., Beaudet A.L. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med. 2000;191:189\u2013194.", "ArticleIdList": ["PMC2195808", "10620617"]}, {"Citation": "Huo Y., Hafezi-Moghadam A., Ley K. Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circ Res. 2000;87:153\u2013159.", "ArticleIdList": ["10904000"]}, {"Citation": "Leisegang M.S., Bibli S.I., G\u00fcnther S., Pfl\u00fcger-M\u00fcller B., Oo J.A., H\u00f6per C., et al. Pleiotropic effects of laminar flow and statins depend on the Kr\u00fcppel-like factor-induced lncRNA MANTIS. Eur Heart J. 2019;40:2523\u20132533.", "ArticleIdList": ["31222221"]}, {"Citation": "Zhou T., You W.T., Ma Z.C., Liang Q.D., Tan H.L., Xiao C.R., et al. Ginkgolide B protects human umbilical vein endothelial cells against xenobiotic injuries via PXR activation. Acta Pharmacol Sin. 2016;37:177\u2013186.", "ArticleIdList": ["PMC4753368", "26775663"]}, {"Citation": "Aky\u00fcrek N., Salman B., Irk\u00f6r\u00fcc\u00fc O., Tezcaner T., Azili C., Erdem O., et al. The effect of platelet activating factor antagonist BN 52021 on bacterial translocation and ICAM-I expression in experimental obstructive jaundice. J Invest Surg. 2005;18:247\u2013256.", "ArticleIdList": ["16249168"]}, {"Citation": "Liu Y.G., Li F.J., Wang J., Wang X.D. Effects of ginkgolide B on inflammation induced by cerebral ischemia\u2013reperfusion in rats. J Chin Med Mater. 2010;33:578\u2013580.", "ArticleIdList": ["20845788"]}, {"Citation": "Ozturk H., Ozturk H., Yagmur Y. PAF antagonist BN-52021 reduces intercellular adhesion molecule-1 expression and oxidative stress in rats with reperfusion damage due to unilateral testicular torsion. Pediatr Surg Int. 2006;22:191\u2013196.", "ArticleIdList": ["16369775"]}, {"Citation": "Sneddon A.A., McLeod E., Wahle K.W., Arthur J.R. Cytokine-induced monocyte adhesion to endothelial cells involves platelet-activating factor: suppression by conjugated linoleic acid. Biochim Biophys Acta. 2006;1761:793\u2013801.", "ArticleIdList": ["16829183"]}, {"Citation": "Woo C.W.H., Cheung F., Chan V.W.H., Siow Y.L., O K Homocysteine stimulates inducible nitric oxide synthase expression in macrophages: antagonizing effect of ginkgolides and bilobalide. Mol Cell Biochem. 2003;243:37\u201347.", "ArticleIdList": ["12619887"]}, {"Citation": "Northover A.M., Northover B.J. Degranulation of rat omental mast cells by A1 receptor agonists in\u00a0vitro. Mediat Inflamm. 1996;5:341\u2013345.", "ArticleIdList": ["PMC2365807", "18475728"]}, {"Citation": "Northover A.M., Northover B.J. Inhibition of NO-synthase and degranulation of rat omental mast cells in\u00a0vitro. Mediat Inflamm. 1996;5:257\u2013261.", "ArticleIdList": ["PMC2365813", "18475736"]}, {"Citation": "Vercellotti G.M., Yin H.Q., Gustafson K.S., Nelson R.D., Jacob H.S. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood. 1988;71:1100\u20131107.", "ArticleIdList": ["2451547"]}, {"Citation": "Lenoir M., Muntaner O., Pedruzzi E., Roch-Arveiller M., Tissot M., Drieu K., et al. Ginkgolide B stimulates signaling events in neutrophils and primes defense activities. Biochem Biophys Res Commun. 2005;335:1149\u20131154.", "ArticleIdList": ["16122706"]}, {"Citation": "Siminiak T., Egdell R.M., O'Gorman D.J., Dye J.F., Sheridan D.J. Plasma-mediated neutrophil activation during acute myocardial infarction: role of platelet-activating factor. Clin Sci (Lond) 1995;89:171\u2013176.", "ArticleIdList": ["7554758"]}, {"Citation": "F\u00f6ldes-Filep E., Braquet P., Filep J. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes. Biochem Biophys Res Commun. 1987;148:1412\u20131417.", "ArticleIdList": ["2825685"]}, {"Citation": "Kurihara K., Wardlaw A.J., Moqbel R., Kay A.B. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021. J Allergy Clin Immunol. 1989;83:83\u201390.", "ArticleIdList": ["2536413"]}, {"Citation": "Yuan D., Sun G., Zhang R., Luo C., Ge M., Luo G., et al. Connexin 43 expressed in endothelial cells modulates monocyte\u2013endothelial adhesion by regulating cell adhesion proteins. Mol Med Rep. 2015;12:7146\u20137152.", "ArticleIdList": ["26324251"]}, {"Citation": "Yuan D., Wang Q., Wu D., Yu M., Zhang S., Li L., et al. Monocyte\u2013endothelial adhesion is modulated by Cx43-stimulated ATP release from monocytes. Biochem Biophys Res Commun. 2012;420:536\u2013541.", "ArticleIdList": ["22446325"]}, {"Citation": "Ji H., Qiu R., Gao X., Zhang R., Li X., Hei Z., et al. Propofol attenuates monocyte\u2013endothelial adhesion via modulating connexin43 expression in monocytes. Life Sci. 2019;232", "ArticleIdList": ["31276689"]}, {"Citation": "Schmitt M.M., Megens R.T., Zernecke A., Bidzhekov K., van den Akker N.M., Rademakers T., et al. Endothelial junctional adhesion molecule\u2014a guides monocytes into flow-dependent predilection sites of atherosclerosis. Circulation. 2014;129:66\u201376.", "ArticleIdList": ["24065611"]}, {"Citation": "Allingham M.J., van Buul J.D., Burridge K. ICAM-1-mediated, Src- and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration. J Immunol. 2007;179:4053\u20134064.", "ArticleIdList": ["17785844"]}, {"Citation": "Tabas I., Bornfeldt K.E. Macrophage phenotype and function in different stages of atherosclerosis. Circ Res. 2016;118:653\u2013667.", "ArticleIdList": ["PMC4762068", "26892964"]}, {"Citation": "Zong P., Feng J., Yue Z., Yu A.S., Vacher J., Jellison E.R., et al. TRPM2 deficiency in mice protects against atherosclerosis by inhibiting TRPM2\u2013CD36 inflammatory axis in macrophages. Nat Cardiovasc Res. 2022;1:344\u2013360.", "ArticleIdList": ["PMC9015693", "35445217"]}, {"Citation": "Loscalzo J. Homocysteine-mediated thrombosis and angiostasis in vascular pathobiology. J Clin Invest. 2009;119:3203\u20133205.", "ArticleIdList": ["PMC2769170", "19841539"]}, {"Citation": "Nikkari S.T., O'Brien K.D., Ferguson M., Hatsukami T., Welgus H.G., Alpers C.E., et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation. 1995;92:1393\u20131398.", "ArticleIdList": ["7664418"]}, {"Citation": "Burleigh M.E., Babaev V.R., Oates J.A., Harris R.C., Gautam S., Riendeau D., et al. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation. 2002;105:1816\u20131823.", "ArticleIdList": ["11956125"]}, {"Citation": "Bouchareychas L., Duong P., Phu T.A., Alsop E., Meechoovet B., Reiman R., et al. High glucose macrophage exosomes enhance atherosclerosis by driving cellular proliferation\u00a0& hematopoiesis. iScience. 2021;24", "ArticleIdList": ["PMC8333149", "34381972"]}, {"Citation": "Wu G., Zhang J., Zhao Q., Zhuang W., Ding J., Zhang C., et al. Molecularly engineered macrophage-derived exosomes with inflammation tropism and intrinsic heme biosynthesis for atherosclerosis treatment. Angew Chem Int Ed Engl. 2020;59:4068\u20134074.", "ArticleIdList": ["31854064"]}, {"Citation": "Sun J., Sukhova G.K., Wolters P.J., Yang M., Kitamoto S., Libby P., et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med. 2007;13:719\u2013724.", "ArticleIdList": ["17546038"]}, {"Citation": "Shi G.-P., Bot I., Kovanen P.T. Mast cells in human and experimental cardiometabolic diseases. Nat Rev Cardiol. 2015;12:643\u2013658.", "ArticleIdList": ["26259935"]}, {"Citation": "Silvestre-Roig C., Braster Q., Ortega-Gomez A., Soehnlein O. Neutrophils as regulators of cardiovascular inflammation. Nat Rev Cardiol. 2020;17:327\u2013340.", "ArticleIdList": ["31996800"]}, {"Citation": "Serizawa A., Nakamura S., Suzuki Baba S., Nakano M. Involvement of platelet-activating factor in cytokine production and neutrophil activation after hepatic ischemia\u2013reperfusion. Hepatology. 1996;23:1656\u20131663.", "ArticleIdList": ["8675190"]}, {"Citation": "Nordestgaard B.G., Chapman M.J., Humphries S.E., Ginsberg H.N., Masana L., Descamps O.S., et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013;34:3478. 390a.", "ArticleIdList": ["PMC3844152", "23956253"]}, {"Citation": "Ridker P.M., Bhatt D.L., Pradhan A.D., Glynn R.J., MacFadyen J.G., Nissen S.E. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. Lancet. 2023;401:1293\u20131301.", "ArticleIdList": ["36893777"]}, {"Citation": "Paneni F., Beckman J.A., Creager M.A., Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34:2436\u20132443.", "ArticleIdList": ["PMC3743069", "23641007"]}, {"Citation": "Kanter J.E., Averill M.M., Leboeuf R.C., Bornfeldt K.E. Diabetes-accelerated atherosclerosis and inflammation. Circ Res. 2008;103:e116\u2013e117.", "ArticleIdList": ["PMC2645267", "18845812"]}, {"Citation": "Santos R.D., Gidding S.S., Hegele R.A., Cuchel M.A., Barter P.J., Watts G.F., et al. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel. Lancet Diabetes Endocrinol. 2016;4:850\u2013861.", "ArticleIdList": ["27246162"]}, {"Citation": "Ference B.A., Ginsberg H.N., Graham I., Ray K.K., Packard C.J., Bruckert E., et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459\u20132472.", "ArticleIdList": ["PMC5837225", "28444290"]}, {"Citation": "Wang J.K., Li Y., Zhao X.L., Liu Y.B., Tan J., Xing Y.Y., et al. Ablation of plasma Prekallikrein decreases low-density lipoprotein cholesterol by stabilizing low-density lipoprotein receptor and protects against atherosclerosis. Circulation. 2022;145:675\u2013687.", "ArticleIdList": ["35189703"]}, {"Citation": "Xue H., Chen X., Yu C., Deng Y., Zhang Y., Chen S., et al. Gut microbially produced indole-3-propionic acid inhibits atherosclerosis by promoting reverse cholesterol transport and its deficiency is causally related to atherosclerotic cardiovascular disease. Circ Res. 2022;131:404\u2013420.", "ArticleIdList": ["35893593"]}, {"Citation": "Jonsson A.L., B\u00e4ckhed F. Role of gut microbiota in atherosclerosis. Nat Rev Cardiol. 2017;14:79\u201387.", "ArticleIdList": ["27905479"]}, {"Citation": "Yang Y., Chen J., Gao Q., Shan X., Wang J., Lv Z. Study on the attenuated effect of ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease. Toxicology. 2020;445", "ArticleIdList": ["32976958"]}, {"Citation": "Ouyang S., You J., Zhi C., Li P., Lin X., Tan X., et al. Ferroptosis: the potential value target in atherosclerosis. Cell Death Dis. 2021;12:782.", "ArticleIdList": ["PMC8355346", "34376636"]}, {"Citation": "Beck J.C., Goodner C.J., Wilson C., Wilson D., Glidden D., Baskin D.G., et al. Effects of ginkgolide B, a platelet-activating factor inhibitor on insulitis in the spontaneously diabetic BB rat. Autoimmunity. 1991;9:225\u2013235.", "ArticleIdList": ["1777555"]}, {"Citation": "Chen K., Sun W., Jiang Y., Chen B., Zhao Y., Sun J., et al. Ginkgolide B suppresses TLR4-mediated inflammatory response by inhibiting the phosphorylation of JAK2/STAT3 and p38 MAPK in high glucose-treated HUVECs. Oxid Med Cell Longev. 2017;2017", "ArticleIdList": ["PMC5529656", "28785380"]}, {"Citation": "Bako H.Y., Ibrahim M.A., Isah M.S., Ibrahim S. Inhibition of JAK\u2013STAT and NF-\u03baB signalling systems could be a novel therapeutic target against insulin resistance and type 2 diabetes. Life Sci. 2019;239", "ArticleIdList": ["31730866"]}, {"Citation": "Kim H., Lim J.J., Shin H.Y., Suh H.J., Choi H.S. Lactobacillus plantarum K8-based paraprobiotics suppress lipid accumulation during adipogenesis by the regulation of JAK/STAT and AMPK signaling pathways. J Funct Foods. 2021;87"}, {"Citation": "Li D.X., Chen W., Jiang Y.L., Ni J.Q., Lu L. Antioxidant protein peroxiredoxin 6 suppresses the vascular inflammation, oxidative stress and endothelial dysfunction in angiotensin II-induced endotheliocyte. Gen Physiol Biophys. 2020;39:545\u2013555.", "ArticleIdList": ["33226363"]}, {"Citation": "Miyabe M., Nakamura N., Saiki T., Miyabe S., Ito M., Sasajima S., et al. Porphyromonas gingivalis lipopolysaccharides promote proliferation and migration of human vascular smooth muscle cells through the MAPK/TLR4 pathway. Int J Mol Sci. 2022;24:125.", "ArticleIdList": ["PMC9820797", "36613563"]}, {"Citation": "Cheng F., Twardowski L., Fehr S., Aner C., Schaeffeler E., Joos T., et al. Selective p38\u03b1 MAP kinase/MAPK14 inhibition in enzymatically modified LDL-stimulated human monocytes: implications for atherosclerosis. FASEB J. 2017;31:674\u2013686.", "ArticleIdList": ["27871059"]}, {"Citation": "Liang X., Wang L., Wang M., Liu Z., Liu X., Zhang B., et al. MicroRNA-124 inhibits macrophage cell apoptosis via targeting p38/MAPK signaling pathway in atherosclerosis development. Aging (Albany NY) 2020;12:13005\u201313022.", "ArticleIdList": ["PMC7377888", "32611832"]}, {"Citation": "Bragg F., Holmes M.V., Iona A., Guo Y., Du H., Chen Y., et al. Association between diabetes and cause-specific mortality in rural and urban areas of China. JAMA. 2017;317:280\u2013289.", "ArticleIdList": ["PMC6520233", "28114552"]}, {"Citation": "Woelkart K., Feizlmayr E., Dittrich P., Beubler E., Pinl F., Suter A., et al. Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans. Phytother Res. 2010;24:445\u2013450.", "ArticleIdList": ["20041430"]}, {"Citation": "Zhao J., Geng T., Wang Q., Si H., Sun X., Guo Q., et al. Pharmacokinetics of ginkgolide B after oral administration of three different ginkgolide B formulations in Beagle dogs. Molecules. 2015;20:20031\u201320041.", "ArticleIdList": ["PMC6332382", "26561795"]}, {"Citation": "Wang S., Ouyang B., Aa J., Geng J., Fei F., Wang P., et al. Pharmacokinetics and tissue distribution of ginkgolide A, ginkgolide B, and ginkgolide K after intravenous infusion of ginkgo diterpene lactones in a rat model. J Pharm Biomed Anal. 2016;126:109\u2013116.", "ArticleIdList": ["27182682"]}, {"Citation": "Lv Z., Yang Y., Wang J., Chen J., Li J., Di L. Optimization of the preparation conditions of borneol-modified ginkgolide liposomes by response surface methodology and study of their blood brain barrier permeability. Molecules. 2018;23:303.", "ArticleIdList": ["PMC6017666", "29385087"]}, {"Citation": "Chai Z., Song Y., Gao C., Wang J. Relative bioavailability of terpene lactones in Beagle dogs after ig administration of domestic and imported Ginkgo Leaf Tables. Chin Tradit Herb Drugs. 2018;49:2840\u20132844."}, {"Citation": "Guan H., Qian D., Ren H., Zhang W., Nie H., Shang E., et al. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats. J Ethnopharmacol. 2014;155:758\u2013768.", "ArticleIdList": ["24953034"]}, {"Citation": "Dong Y., Zhang J., Wang Y., Zhao L., Li R., Wei C., et al. Effect of ginkgolide in ischemic stroke patients with large artery atherosclerosis: results from a randomized trial. CNS Neurosci Ther. 2021;27:1561\u20131569.", "ArticleIdList": ["PMC8611772", "34676982"]}, {"Citation": "Nishimon S., Yamaguchi M., Muraki H., Sakai N., Nishino S. Intraperitoneal injection of ginkgolide B, a major active compound of Ginkgo biloba, dose-dependently increases the amount of wake and decreases non-rapid eye movement sleep in C57BL/6 mice. Neurosci Lett. 2020;722", "ArticleIdList": ["32050100"]}, {"Citation": "Yan-yan L., Jun T. Effect of rosuvastatin combined with Ginkgo Biloba Leaves extract tablets on carotid atherosclerotic plaques and dyslipidemia in patients with cerebral infarction. J Xinxiang Med Univ. 2016;33:133\u2013135."}, {"Citation": "Ke S., Qingcheng Y. The impact of rosuvastatin combined with Ginkgo biloba extract tablets on carotid atherosclerotic plaque and inflammatory response in patients with ischemic stroke and diabetes. Chin J Gerontol. 2017;37:1933\u20131935."}, {"Citation": "Kressmann S., Biber A., Wonnemann M., Schug B., Blume H.H., M\u00fcller W.E. Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations. J Pharm Pharmacol. 2002;54:1507\u20131514.", "ArticleIdList": ["12495553"]}, {"Citation": "Qin Y., Chen T., Jin Q., Guo K., Feng H., Heller D., et al. Pharmacokinetics, metabolism and disposition of [14C]XQ-1H after intravenous administration to male rats. Drug Metabol Lett. 2017;10:228\u2013239.", "ArticleIdList": ["28103788"]}, {"Citation": "Yang Q., Fang W., Lv P., Geng X., Li Y., Sha L. Therapeutic neuroprotective effects of XQ-1H in a rat model of permanent focal cerebral ischemia. Pharmacology. 2012;89:1\u20136.", "ArticleIdList": ["22178991"]}, {"Citation": "Zhang X., Zhong W., Ma X., Zhang X., Chen H., Wang Z., et al. Ginkgolide with intravenous alteplase thrombolysis in acute ischemic stroke improving neurological function: a multicenter, cluster-randomized trial (GIANT) Front Pharmacol. 2021;12", "ArticleIdList": ["PMC8681856", "34925044"]}, {"Citation": "Zhu P.C., Tong Q., Zhuang Z., Wang Z.H., Deng L.H., Zheng G.Q., et al. Ginkgolide B for myocardial ischemia/reperfusion injury: a preclinical systematic review and meta-analysis. Front Physiol. 2019;10:1292.", "ArticleIdList": ["PMC6807679", "31681006"]}, {"Citation": "Li X., Huang L., Liu G., Fan W., Li B., Liu R., et al. Ginkgo diterpene lactones inhibit cerebral ischemia/reperfusion induced inflammatory response in astrocytes via TLR4/NF-\u03baB pathway in rats. J Ethnopharmacol. 2020;249", "ArticleIdList": ["31678414"]}, {"Citation": "Shu Z.M., Shu X.D., Li H.Q., Sun Y., Shan H., Sun X.Y., et al. Ginkgolide B protects against ischemic stroke via modulating microglia polarization in mice. CNS Neurosci Ther. 2016;22:729\u2013739.", "ArticleIdList": ["PMC6492915", "27306494"]}, {"Citation": "Yang X., Zheng T., Hong H., Cai N., Zhou X., Sun C., et al. Neuroprotective effects of Ginkgo biloba extract and ginkgolide B against oxygen\u2013glucose deprivation/reoxygenation and glucose injury in a new in\u00a0vitro multicellular network model. Front Med. 2018;12:307\u2013318.", "ArticleIdList": ["29058254"]}, {"Citation": "Gu J.H., Ge J.B., Li M., Wu F., Zhang W., Qin Z.H. Inhibition of NF-\u03baB activation is associated with anti-inflammatory and anti-apoptotic effects of ginkgolide B in a mouse model of cerebral ischemia/reperfusion injury. Eur J Pharmaceut Sci. 2012;47:652\u2013660.", "ArticleIdList": ["22850444"]}, {"Citation": "Zheng P.D., Mungur R., Zhou H.J., Hassan M., Jiang S.N., Zheng J.S. Ginkgolide B promotes the proliferation and differentiation of neural stem cells following cerebral ischemia/reperfusion injury, both and. Neural Regen Res. 2018;13:1204\u20131211.", "ArticleIdList": ["PMC6065216", "30028328"]}, {"Citation": "Raheem S.G. Investigating platelet-activating factor as a potent proinflammatory mediator in coronary atherosclerotic patients. Cell Mol Biol. 2021;67:1\u20134.", "ArticleIdList": ["34933739"]}, {"Citation": "Sumita C., Yamane M., Matsuda T., Maeda M., Nariai T., Fujio Y., et al. Platelet activating factor induces cytoskeletal reorganization through Rho family pathway in THP-1 macrophages. FEBS Lett. 2005;579:4038\u20134042.", "ArticleIdList": ["16004986"]}, {"Citation": "Quiroga J., Alarc\u00f3n P., Manosalva C., Taubert A., Hermosilla C., Hidalgo M.A., et al. Glycolysis and mitochondrial function regulate the radical oxygen species production induced by platelet-activating factor in bovine polymorphonuclear leukocytes. Vet Immunol Immunopathol. 2020;226", "ArticleIdList": ["32540687"]}, {"Citation": "Gavriil L., Detopoulou M., Petsini F., Antonopoulou S., Fragopoulou E. Consumption of plant extract supplement reduces platelet activating factor-induced platelet aggregation and increases platelet activating factor catabolism: a randomised, double-blind and placebo-controlled trial. Br J Nutr. 2019;121:982\u2013991.", "ArticleIdList": ["30940217"]}, {"Citation": "Cirillo P., Golino P., Ragni M., Battaglia C., Pacifico F., Formisano S., et al. Activated platelets and leucocytes cooperatively stimulate smooth muscle cell proliferation and proto-oncogene expression via release of soluble growth factors. Cardiovasc Res. 1999;43:210\u2013218.", "ArticleIdList": ["10536706"]}, {"Citation": "Wu G., Cai J., Han Y., Chen J., Huang Z.P., Chen C., et al. LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circulation. 2014;130:1452\u20131465.", "ArticleIdList": ["PMC4244705", "25156994"]}, {"Citation": "Mao Y.J., Wang L., Wang W.J. Effect of ginkgolide B on the function of rat aorta smooth cells and U937 cells stimulated by oxLDL. Acta Pharm Sin. 2006;41:36\u201340.", "ArticleIdList": ["16683525"]}, {"Citation": "Wei E.H., Rao M.R., Ji N.D., Chen X.Y., Chen Q. Inhibitory effects of ginkgolide B on proliferation of bovine aortic smooth muscle cells. Acta Pharm Sin. 2002;37:90\u201393.", "ArticleIdList": ["12579949"]}, {"Citation": "Liu Y., Liu W., Xiong S., Luo J., Li Y., Zhao Y., et al. Highly stabilized nanocrystals delivering ginkgolide B in protecting against the Parkinson's disease. Int J Pharm. 2020;577", "ArticleIdList": ["31981707"]}, {"Citation": "Zhao Y., Xiong S., Liu P., Liu W., Wang Q., Liu Y., et al. Polymeric nanoparticles-based brain delivery with improved therapeutic efficacy of ginkgolide B in Parkinson's disease. Int J Nanomed. 2020;15:10453\u201310467.", "ArticleIdList": ["PMC7769078", "33380795"]}, {"Citation": "Liu W., Li P., Feng F., Mao L. Isolation and structure characterization of related impurities in 10-O-(N,N-dimethylaminoethyl)-ginkgolide B methanesulfonate (XQ-1H) bulk drug and quantitation by a validated RP-LC. J Pharm Biomed Anal. 2010;52:603\u2013608.", "ArticleIdList": ["20138458"]}, {"Citation": "Fei Y., Zhao B., Zhu J., Fang W., Li Y. XQ-1H promotes cerebral angiogenesis via activating PI3K/Akt/GSK3\u03b2/\u03b2-catenin/VEGF signal in mice exposed to cerebral ischemic injury. Life Sci. 2021;272", "ArticleIdList": ["33607158"]}, {"Citation": "Xu D., Hou K., Li F., Chen S., Fang W., Li Y. XQ-1H alleviates cerebral ischemia in mice through inhibition of apoptosis and promotion of neurogenesis in a Wnt/\u03b2-catenin signaling dependent way. Life Sci. 2019;235", "ArticleIdList": ["31499069"]}, {"Citation": "Li Y., Zhang M., Li S., Zhang L., Kim J., Qiu Q., et al. Selective ischemic-hemisphere targeting ginkgolide B liposomes with improved solubility and therapeutic efficacy for cerebral ischemia\u2013reperfusion injury. Asian J Pharm Sci. 2023;18", "ArticleIdList": ["PMC9986716", "36891470"]}, {"Citation": "Liang X., Li H., Li X., Tian X., Zhang A., Luo Q., et al. Highly sensitive H2O2-scavenging nano-bionic system for precise treatment of atherosclerosis. Acta Pharm Sin B. 2023;13:372\u2013389.", "ArticleIdList": ["PMC9939301", "36815039"]}, {"Citation": "Jia X., Bai X., Yang X., Wang L., Lu Y., Zhu L., et al. VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis. Metabolism. 2022;135", "ArticleIdList": ["35917895"]}, {"Citation": "Li X., Chen X., Zheng L., Chen M., Zhang Y., Zhu R., et al. Non-canonical STING\u2013PERK pathway dependent epigenetic regulation of vascular endothelial dysfunction via integrating IRF3 and NF-\u03baB in inflammatory response. Acta Pharm Sin B. 2023;13:4765\u20134784.", "ArticleIdList": ["PMC10692388", "38045042"]}, {"Citation": "Tsvetkov P., Coy S., Petrova B., Dreishpoon M., Verma A., Abdusamad M., et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254\u20131261.", "ArticleIdList": ["PMC9273333", "35298263"]}]}], "History": [{"Year": "2023", "Month": "6", "Day": "8"}, {"Year": "2023", "Month": "9", "Day": "3"}, {"Year": "2023", "Month": "9", "Day": "13"}, {"Year": "2024", "Month": "1", "Day": "19", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "1", "Day": "19", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "19", "Hour": "3", "Minute": "36"}, {"Year": "2023", "Month": "9", "Day": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38239238", "PMC10792990", "10.1016/j.apsb.2023.09.014", "S2211-3835(23)00367-2"]}}]}